Patent details

Basic Information

Publication number:

EP1946771

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP081538456

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Multivalent vaccine composition

French Title of Invention:

Composition vaccinale

German Title of Invention:

Impfstoffzusammensetzung

SPC Number:

Dates

Filing date:

28/03/2002

Grant date:

27/06/2012

EP Publication Date:

27/06/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/07/2008

EP B1 Publication Date:

27/06/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/03/2014

Expiration date:

28/03/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/03/2002

 

 

Name:

GlaxoSmithKline Biologicals S.A.

Address:

rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

Agent

Name:

KIRKPATRICK SA / NV

From:

01/08/2012

Address:

AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)

To:

Inventor

1

Name:

Desmons Pierre Michel c/o GlaxoSmithKline Biologicals s.a.

Address:

Belgium (BE)

2

Name:

Capiau Carine c/o GlaxoSmithKline Biologicals s.a.

Address:

Belgium (BE)

3

Name:

Poolman Jan c/o GlaxoSmithKline Biologicals s.a.

Address:

Belgium (BE)

4

Name:

Boutriau Dominique c/o GlaxoSmithKline Biologicals s.a.

Address:

Belgium (BE)

5

Name:

Lemoine Dominique c/o GlaxoSmithKline Biologicals s.a.

Address:

Belgium (BE)

Priority

Priority Number:

0108364

Priority Date:

03/04/2001

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 39/385;

Filing date	Document type	Number of pages